This antibody-cytokine fusion protein was achieved by conjugating/fusing the Anti-EDB scFv to IL12. It was expressed in CHO and purified with affinity chromatography. The immunocytokine retains the ability to bind the EDB as well as the biological activity of IL12. The fusion protein displays an excellent tumor targeting performance in vivo. Considering the fact that the tumor targeting ability of scFv (L19) in patients with cancer has been demonstrated using scintigraphic methods, and that scFv (L19)-based antibody-cytokine fusion are currently entering clinical trials. This immunocytokine was designed for treating Advanced solid tumors, Advanced pancreatic cancer, Metastatic melanoma.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1294z | Mouse Anti-FN1 Recombinant Antibody (clone 6H4) | IHC, IP, WB | Mouse IgG2b, κ |
MOB-0025MZ | Recombinant Mouse Anti-Human Fibronectin Antibody (clone C715M) | ELISA | Mouse antibody |
FAMAB-0105YC | Human Anti-FN1 Recombinant Antibody (clone ME4C) | ELISA, IHC | Human IgG |
ZG-0661F | Rabbit Anti-FN1 Recombinant Antibody (ZG-0661F) | IF, IHC-P, ELISA, RIA | Rabbit IgG |
ZG-0662F | Rabbit Anti-FN1 Recombinant Antibody (ZG-0662F) | IF, IHC-P, ELISA, RIA | Rabbit IgG |
There are currently no Customer reviews or questions for ACFP-SH089. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.